Literature DB >> 10382699

Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease.

N C Fox, E K Warrington, M N Rossor.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10382699     DOI： 10.1016/S0140-6736(99)00496-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  39 in total

1.  Loss of presynaptic and postsynaptic structures is accompanied by compensatory increase in action potential-dependent synaptic input to layer V neocortical pyramidal neurons in aged rats.

Authors:  T P Wong; G Marchese; M A Casu; A Ribeiro-da-Silva; A C Cuello; Y De Koninck
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

Authors:  C R Jack; M M Shiung; S D Weigand; P C O'Brien; J L Gunter; B F Boeve; D S Knopman; G E Smith; R J Ivnik; E G Tangalos; R C Petersen
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

3.  Hippocampal hypometabolism predicts cognitive decline from normal aging.

Authors:  Lisa Mosconi; Susan De Santi; Juan Li; Wai Hon Tsui; Yi Li; Madhu Boppana; Eugene Laska; Henry Rusinek; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2007-01-11       Impact factor: 4.673

4.  The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition.

Authors:  J He; V S S Wong; E Fletcher; P Maillard; D Y Lee; A-M Iosif; B Singh; O Martinez; A E Roach; S N Lockhart; L Beckett; D Mungas; S T Farias; O Carmichael; C DeCarli
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

Review 5.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 6.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

7.  Compromised hemodynamic response in amyloid precursor protein transgenic mice.

Authors:  Thomas Mueggler; Christine Sturchler-Pierrat; Diana Baumann; Martin Rausch; Matthias Staufenbiel; Markus Rudin
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

8.  Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.

Authors:  Jing He; Sarah Farias; Oliver Martinez; Bruce Reed; Dan Mungas; Charles Decarli
Journal:  Arch Neurol       Date:  2009-11

9.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

10.  Effect of leukocyte telomere length on total and regional brain volumes in a large population-based cohort.

Authors:  Kevin S King; Julia Kozlitina; Roger N Rosenberg; Ronald M Peshock; Roderick W McColl; Christine K Garcia
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.